Interferon-γ-dependent in vitro model for the putative keratin 17 autoimmune loop in psoriasis: Exploration of pharmaco- and gene-therapeutic effects

Skin Pharmacology and Physiology

Volumn 18, Issue 1, 2005, Pages 42-54

  Bockelmann R ^a   Horn, T ^a   Gollnick, H ^a   Bonnekoh, B ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Acitretin; Antisense oligonucleotides; Bay 11 7082; Bay 11 7085; Corticosteroids; Gene therapy; Imatinib

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ANTIPSORIASIS AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; BAY 117085; DEXAMETHASONE; ETRETIN; GAMMA INTERFERON; HYDROCORTISONE ACETATE; I KAPPA B; IMATINIB; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; KERATIN; KERATIN 17; PROTEIN TYROSINE KINASE INHIBITOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EPIDERMIS; GENE THERAPY; HUMAN; HUMAN CELL; HYPOTHESIS; KERATINOCYTE; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PSORIASIS;

ACITRETIN; ADRENAL CORTEX HORMONES; ANTI-INFECTIVE AGENTS; APOPTOSIS; AUTOIMMUNITY; CELL LINE; CYTOKINES; HUMANS; INTERFERON TYPE II; KERATINOCYTES; KERATINS; KERATOLYTIC AGENTS; NITRILES; OLIGONUCLEOTIDES, ANTISENSE; PIPERAZINES; PSORIASIS; PYRIMIDINES; SULFONES;

EID: 11444269456     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081685     Document Type: Article

References (33)

1. Lebwohl M: Psoriasis. Lancet 2003;361:1197-1204.
2. Mehlis SL, Gordon KB: The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol 2003;49(2 suppl):S44-S50.
3. Nickoloff BJ, Wrone-Smith T: Injection of prepsoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 1999;155:145-158.
4. Weinberg JM: An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis. Clin Ther 2003;25:2487-2505.
5. Elder JT, Nair RP, Henseler T, Jenisch S, Stuart P, Chia N, Christophers E, Voorhees JJ: The genetics of psoriasis 2001: The odyssey continues. Arch Dermatol 2001;137:1447-1454.
6. Capon F, Munro M, Barker J, Trembath R: Searching for the major histocompatibility complex psoriasis susceptibility gene. J Invest Dermatol 2002;118:745-751.
7. Davison SC, Allen MH, Mallon E, Barker JNWN: Contrasting patterns of streptococcal superantigen-induced T-cell proliferation in guttate vs chronic plaque psoriasis. Br J Dermatol 2001;145:245-251.
8. Barton AC: Genetic epidemiology. Psoriatic arthritis. Arthritis Res 2002;4:247-251.
9. Böckelmann R, Neugebauer P, Paseban ND, Hüttemann M, Gollnick H, Bonnekoh B: Suprabasal overexpression of the hsRPB7-gene in psoriatic epidermis as identified by a RT/PCR differential display model comparing psoriasis plaque tissue with peritonsillar mucosa. Am J Pathol 2001;158:367-372.
10. Austin LM, Coven TR, Bhardwaj N, Steinmann R, Krueger JG: Intraepidermal lymphocytes in psoriatic lesions are activated GMP-17(TIA-1)+CD8+CD3+ CTLs as determined by phenotypic analysis. J Cutan Pathol 1998;25:79-88.
11. Behrendt C, Gollnick H, Bonnekoh B: Up-regulated perforin expression of CD8+ blood lymphocytes in generalized non-anaphylactic drug eruptions and exacerbated psoriasis. Eur J Dermatol 2000;10:356-369.
12. Gudmundsdottir AS, Sigmundsdottir H, Sigurgeirsson B, Good MF, Valdimarsson H, Jonsdottir I: Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis? Clin Exp Immunol 1999;117:580-586.
13. Moll R, Franke WW, Schiller DL: The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
14. DeJong EMGJ, van Vlijmen IMMJ, van Erp PEJ, Ramaekers FCS, Troyanowski SM, van de Kerkhof PCM: Keratin 17: A useful marker in anti-psoriatic therapies. Arch Dermatol Res 1991;283:480-482.
15. Flohr T, Buwitt U, Bonnekoh B, Decker T, Böttger EC: Interferon-gamma regulates expression of a novel keratin class I gene. Eur J Immunol 1992;22:975-979.
16. Bonnekoh B, Huerkamp C, Wevers A, Geisel J, Sebok B, Bange FC, Greenhalgh DA, Boettger EC, Krieg T, Mahrle G: Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gamma. J Invest Dermatol 1995;104:58-61.
17. Bjerke JR, Livden JK, Degré M, Matre R: Interferon in suction blister fluid from psoriatic lesions. Br J Dermatol 1983;108:295-299.
18. Barker JNWN, Karabin GD, Stoof TJ, Sarma VJ, Dixit VM, Nickoloff BJ: Detection of interferon-gamma mRNA in psoriatic epidermis by polymerase chain reaction. J Dermatol Sci 1991;2:106-111.
19. Bonnekoh B, Böckelmann R, Ambach A, Gollnick H: Dithranol and dimethylfumarate suppress the interferon-gamma-induced up-regulation of cytokeratin 17 as a putative psoriasis autoantigen in-vitro. Skin Pharmacol Appl Skin Physiol 2001;14:217-225.
20. 2 laser resurfacing. J Cosmet Laser Ther 2001;3:123-127.
21. Nickoloff BJ, Wrone-Smith T, Bonish B, Porcelli SA: Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: Detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161. Arch Dermatol 1999;135:546-552.
22. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988;106:761-771.
23. Gandarillas A, Goldsmith LA, Gschmeissner S, Leigh IM, Watt FM: Evidence that apoptosis and terminal differentiation of epidermal keratinocytes are distinct processes. Exp Dermatol 1999;8:71-79.
24. Takahashi H, Manabe A, Ishida-Yamamoto A, Hashimoto Y, Iizuka H: Aberrant expression of apoptosis-related molecules in psoriatic epidermis. J Dermatol Sci 2002;28:187-197.
25. Troyanovsky, SM, Leube RE, Franke WW: Characterization of the human gene encoding cytokeratin 17 and its expression pattern. Eur J Cell Biol 1992;59:127-137
26. Vogel U, Denecke B, Troyanovsky SM, Leube RE, Bottger EC: Transcriptional activation of psoriasis-associated cytokeratin K17 by interferon-gamma. Analysis of gamma-interferon activation sites. Eur J Biochem 1995;227:143-149.
27. Roos TC, Jugert FK, Merk HF, Bickers DR: Retinoid metabolism in the skin. Pharmacol Rev 1998;50:315-333.
28. Miyagawa S, Fujimoto H, Ko S, Hirota S, Kitamura Y: Improvement of psoriasis during imatinib therapy in a patient with a metastatic gastrointestinal stromal tumour. Br J Dermatol 2002;147:406-407.
29. Buchdunger E, Cioffi CL, Law N, Stover D, Ohno-Jones S, Druker BJ, Lydon NB: The Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and PDGF receptors. J Pharmacol Exp Ther 2000;295:139-145.
30. Brouard MC, Prins C, Mach-Pascual S, Saurat JH: Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukemia. Dermatology 2001;203:57-59.
31. Mori N, Yamad Y, Ikeda S, Yamasaki Y, Tsukasaki K, Tanaka Y, Tomonaga M, Yamamoto N, Fujii M: Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-1-infected T-cell lines and primary adult T-cell leukemia cells. Blood 2002;100:1828-1834.
32. Scaife CL, Kuang J, Wills JC, Trowbridge DB, Gray P, Manning BM, Eichwald EJ, Daynes RA, Kuwada SK: Nuclear factor kappa B inhibitors induce adhesion-dependent colon cancer apoptosis: Implications for metastasis. Cancer Res 2002;62:6870-6878.
33. White PJ, Gray AC, Fogarty RD, Sinclair RD, Thumiger SP, Werther GA, Wraight CJ: C-5 propyne-modified oligonucleotides penetrate the epidermis in psoriatic and not normal human skin after topical application. J Invest Dermatol 2002;118:1003-1007.